Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits

Molecular and Cellular Biochemistry

Volumn 186, Issue 1-2, 1998, Pages 3-12

  Miki, Takayuki ^a   Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Ischemic preconditioning; Morphine; Naloxone; Opioid receptor; Protein kinase C; Rabbit

Indexed keywords

CHELERYTHRINE; MORPHINE; NALOXONE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PROTEIN KINASE C; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RABBIT; REPERFUSION;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NALOXONE; NARCOTIC ANTAGONISTS; PHENANTHRIDINES; PROTEIN KINASE C; RABBITS; RECEPTORS, OPIOID;

EID: 0031785918     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006856124501     Document Type: Article

References (48)

1. Miura T, Iimura O: Infarct size limitation by preconditioning: Its phenomenological features and the key role of adenosine. Cardiovasc Res 27: 36-42, 1993
2. Downey JM, Miura T: The role of adenosine in ischemic preconditioning. In: M Hori, Y Maruyama, RS Reneman (eds). Cardiac Adaptation and Failure. Springer-Verlag, Tokyo, 1994, pp 147-166
3. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991
4. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 29: 682-688, 1995
5. Wall TM, Sheehy R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270: 681-689, 1994
6. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995
7. Baines CP, Goto M, Downey JM: Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29: 207-216, 1997
8. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S: Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 28: 980-986, 1994
9. Ytrehus K, Liu Y, Downey JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152, 1994
10. Liu Y, Ytrehus K, Downey JM: Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668, 1994
11. Chen Y-T, Lin C-J, Lee AY-S: Plasma levels of endogenous opioid peptides in patients with acute myocardial infarction. Jpn Heart J 36: 421-427, 1995
12. Holaday JW: Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol 23: 541-594, 1983
13. Schultz JEJ, Rose E, Yao Z, Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157-H2161, 1995
14. Headrick JP: Ischemic preconditioning: Bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28: 1227-1240, 1996
15. Liu Y, Downey JM: Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263: H1107-H1112, 1992
16. Chien GL, Van Winkle DM: Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol 28: 1895-1900, 1996
17. 2-agonists in locus coeruleus neurons. Brain Res 371: 390-394, 1986
18. Burns DL, Hewlett EL, Moss J, Vaughan M: Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J Biol Chem 258: 1435-1438, 1983
19. Mangoura D, Dawson G: Opioid peptides activate phospholipase D and protein kinase C-ε in chicken embryo neuron cultures. Proc Natl Acad Sci USA 90: 2915-2919, 1993
20. Birnbaum Y, Hale SL, Kloner RA: Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 29: 657-666, 1997
21. Ytrehus K, Liu Y Tsuchida A, Miura T, Liu GS, Yang X-M, Herbert D, Cohen MV, Downey JM: Rat and rabbit heart infarction: Effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267: H2383-H2390, 1994
22. Lee AY-S, Chen Y-T, Kan M-N, P'eng F-K, Chai C-Y, Kuo J-S: Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease. Cardiovasc Res 26: 392-395, 1992
23. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O: Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 26: 456-461, 1992
24. Liang C-S, Imai N, Stone CK, Woolf PD, Kawashima S, Tuttle RR: The role of endogenous opioids in congestive heart failure: Effects of nalmefene on systemic and regional hemodynamics in dogs. Circulation 75: 443-451, 1987
25. Kan MN, Chen YT, Lee AYS: Naloxone reversal of ischemic arrhythmia is stereospecific and suggests role of endogenous opioid peptides in ischemic heart disease. Proc Soc Exp Biol Med 200: 518-521, 1992
26. Lee AY-S: Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog. Br J Pharmacol 107: 1057-1060, 1992
27. 5]-enkephalin). J Thorac Cardiovasc Surg 107: 964-967, 1994
28. Thornton JD, Daly JE, Cohen MV, Yang X-M, Downey JM: Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 73: 649-655, 1993
29. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585, 1994
30. Liu Y, Tsuchida A, Cohen MV, Downey JM: Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883-892, 1995
31. Wang P, Gallagher KP, Downey JM, Cohen MV: Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 28: 579-588, 1996
32. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C: Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74, 1989
33. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 70: 66-81, 1992
34. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM: Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 94: 1713-1718, 1996
35. Paterson SJ, Robson LE, Kosterlitz HW: Classification of opioid receptors. Br Med Bull 39: 31-36, 1983
36. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A: Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73-81, 1995
37. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA: Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557, 1995
38. Vahlhaus C, Schulz R, Post H, Onallah R, Heusch G: No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 79: 407-414, 1996
39. Kita H, Miura T, Tsuchida A, Sakamoto J, Iimura O: Roles of opioid receptor and protein kinase C in suppression of reperfusion arrhythmia by preconditioning. J Mol Cell Cardiol 27: (abstr) A520, 1995
40. Schultz JEJ, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104, 1996
41. North RA, Williams JT, Surprenant A, Christie MJ: μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84: 5487-5491, 1987
42. Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Iimura O: Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 25: 531-538, 1995
43. ATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 28: 1337-1341, 1994
44. Heel RC, Avery GS: Appendix A. Drug data information. In: GS Avery (ed). Drug Treatment. Principles and Practice of Clinical Pharmacology and Therapeutics. Second edition. Adis Press, Sydney, 1980, 1211-1222
45. Stanski DR, Greenblatt DJ, Lowenstein E: Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 24: 52-59, 1978
46. Barron BA, Gu H, Gaugl JF, Caffrey JL: Screening for opioids in dog heart. J Mol Cell Cardiol 24: 67-77, 1992
47. Lang RE, Hermann K, Dietz R, Gaida W, Ganten D, Kraft K, Unger T: Evidence for the presence of enkephalins in the heart. Life Sci 32: 399-406, 1983
48. Weihe E, McKnight AT, Corbett AD, Kosterlitz HW: Proenkephalin- and prodynorphin-derived opioid peptides in guinea-pig heart. Neuropeptides 5: 453-456, 1985